Wenyan Jiang
Molecular Biology · 2013–2016
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 94 citations into it; #7,062 of 17,773 by trust here, #1,025 by citations
Whom Wenyan Jiang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Wenyan Jiang overall
- Rodolphe Barrangou
- P. Hsu
- Jennifer A. Doudna
- Hui Yang
- L. Marraffini
- Haifeng Wang
- Satish Sharma
- Hongyi Li
- Thomas J. Cradick
- Feng Zhang
Papers from Wenyan Jiang's perspective
Ordered by how strongly the researchers Wenyan Jiang trusts endorse each paper. Same corpus, a different order for every researcher.
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA (Nature)
- CRISPR/Cas, the Immune System of Bacteria and Archaea (Science)
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors (Science)
- Evolution and classification of the CRISPR-Cas systems (Nature Reviews Microbiology)
- RepSeq – A database of amino acid repeats present in lower eukaryotic pathogens (BMC Bioinformatics)
- Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system (Nucleic Acids Research)
- CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. (Annual Review of Genetics)
- The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing (PLoS Biology)
- Mechanisms of gene silencing by double-stranded RNA (Nature)
- CRISPR-Cas systems for genome editing, regulation and targeting (Nature Biotechnology)
Their papers
- Multiplex Genome Engineering Using CRISPR/Cas Systems (2013) — 14,644 citations
- CRISPR-assisted editing of bacterial genomes (2013) — 1,843 citations
- Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system (2013) — 1,113 citations
- Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases (2014) — 799 citations
- rNA-guided editing of bacterial genomes using crisPr-cas systems (2016)